Christopher B. Ehrlich, Director at BIOMIMETIC THERAPEUTICS, INC. (BMTI), bought 1,250 shares at $8.00 ($10K) on 2006-05-15, disclosed to the SEC on 2006-05-16.
Open-market purchase of $10k BMTI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| EFTR | BUY | 2022-02-22 | $13K | — | Filing → |
| EFTR | BUY | 2022-02-10 | $10K | — | Filing → |
| EFTR | BUY | 2022-02-07 | $31K | — | Filing → |